Newsweek - National News, World News, Health, Technology, Entertainment and more... | Newsweek.com

HEADLINE HEADLINE HEADLINE

SPONSORED BY
  • Mammograms, Pap Smears, and the PSA: How Other Screening Tests Measure Up

    Krista Gesaman | Nov 20, 2009 03:14 PM

    Earlier this week the U.S. Preventive Services Task Force shocked legions of women when it recommended waiting until 50 for a first mammogram, despite previous recommendations that women begin mammograms at 40. Then today, the American College of Obstetricians and Gynecologists released new guidelines for Pap smears. Previously, all sexually active women were encouraged to get the test—which examines cells in the cervix to determine whether there are any abnormalities that could lead to cancer—every year. Now, the recommendations state that women begin the Pap test at 21, retest every other year, and then, once women hit their 30s, schedule a test every three years.

    Quite often, new technology hits the market before long-term studies have been completed, says Ted Epperly, a family physician and past president of the American Academy of Family Physicians. Only after years of using the equipment can experts then gather statistics about their efficacy. And, Epperly suggests, there may be other tests once considered annual necessities that are now being reevaluated in light of new evidence. We asked Epperly to evaluate other preventative tests—once considered lifesavers—and relay what the evidence currently suggests. As always, be sure to check with your doctor about your individual risks and treatment plan
    More
  • Is Motherhood Keeping Good Scientists Down? How to Fix Research's "Mommy Gap"

    Newsweek | Nov 19, 2009 11:01 AM
  • Advertisement
  • There Is No Such Thing As Female Viagra: Flibanserin Can't Change Why Some Women Don't Want Sex

    Newsweek | Nov 18, 2009 10:42 AM
    by Barbara Kantrowitz

    Back in the pre-Viagra age, men were actually impotent. Now, guys with a mechanical problem suffer from erectile dysfunction (E.D. in the ubiquitous TV ads), clearly one of Big Pharma’s most successful rebranding efforts. But women have been denied a similar makeover for their sexual problems because no one has yet figured out why some want it all the time and others hardly ever. If you’re too tired, you’re just plain frigid.

    That could change with the announcement this week that a pill that appears to increase sexual desire in women with low libidos. This potential blockbuster, developed by the German drug manufacturer Boehringer Ingelheim, is called flibanserin and it was almost a nonstarter when it was first tested as an antidepressant. Flibanserin didn’t lift mood, but researchers noticed that it had one intriguing quality: it appeared to heighten sexual interest in laboratory animals and humans.

    Could it be Big Pharma’s Holy Grail: a female Viagra? No doubt inspired by the tantalizing possibility of gazillions in worldwide sales, Boehringer paid for clinical trials of flibanserin in nearly 2,000 premenopausal European, American, and Canadian women suffering from hypoactive sexual desire disorder, a controversial diagnosis that reportedly affects as many as one in four women.

    The results, presented earlier this week at the Congress of the European Society for Sexual Medicine in Lyon, France, showed that the women in the trial who took a daily dose of 100 milligrams of flibanserin for about six months increased the number of “sexually satisfying events” (not necessarily orgasm) to an average of 4.5 from 2.8 in the North American arm of the trial, compared to 3.7 in the placebo group.The women on flibanserin also said they were more interested in sex than those taking a placebo.

    Flibanserin won’t be on sale any time soon. Boehringer still needs to get approval from the FDA and other regulatory bodies around the world, a process which could take years.

    Still, the announcement has already ignited the smoldering debate about the causes and even the definition of sexual dysfunction in women. Sex researchers (mostly men) used to believe that healthy women were just like them, always on the prowl for the right moment. Women who didn’t experience a constant undercurrent of sexual desire were considered abnormal.

    But in recent years, female researchers (most notably University of British Columbia psychiatrist Rosemary Basson) have come to a very different conclusion. Basson and her colleagues have found that while men’s sexual progression is essentially linear─from desire to arousal to orgasm─women’s sexuality is more accurately circular, with one positive factor (such as emotional satisfaction or intimacy) reinforcing others and eventually leading to desire and arousal.

    A woman is most like a man early in a relationship, when she is full of sexual excitement over a new lover. But women in long-term relationships tend to need more stimuli, and that means a guy who satisfies them emotionally (doing the dishes always helps) as well as physically. Women may also steer away from sex because of a large number of nonsexual disorders, including depression, alcoholism, hormonal problems, and even vaginal pain with penetration.

    According to Boehringer, the women in the flibanserin study were only suffering from hypoactive sexual desire disorder, not any other condition that could have hampered their sex drive. But that diagnosis is highly controversial. In order to figure out what it means, you have to define a normal sex drive. No one really knows whether normal means wanting sex once a day, once a month or once a year. Sex researchers currently say that a woman’s sex drive is dysfunctional only if she’s unhappy about it, if it causes her personal distress. That’s why the estimate of how many women suffer from sexual dysfunction ranges from 9 percent to as high as 26 percent.

    Such nuance could vanish if Boehringer eventually wins approval for flibanserin. It’s a good bet that right now there are marketers already testing out brand names and a catchy new label for the old frigid. Any ideas?

    Barbara Kantrowitz writes the "Her Body" column for Newsweek.com

  • The Real Problem With Mammograms: They're Too Good at Finding Things We Don't Understand

    Kate Dailey | Nov 17, 2009 05:32 PM
    This week, the United States Preventive Services Task Force revised their guidelines for breast cancer screening to be more conservative. Previously, women over 40 were encouraged to schedule a mammogram every year. Now, USPSTF says that women can wait until 50.

    According to the New York Times,

    While many women do not think a screening test can be harmful, medical experts say the risks are real. A test can trigger unnecessary further tests, like biopsies, that can create extreme anxiety. And mammograms can find cancers that grow so slowly that they never would be noticed in a woman’s lifetime, resulting in unnecessary treatment.

    Overall, the report says, the modest benefit of mammograms — reducing the breast cancer death rate by 15 percent — must be weighed against the harms. And those harms loom larger for women in their 40s, who are 60 percent more likely to experience them than women 50 and older but are less likely to have breast cancer, skewing the risk-benefit equation. The task force concluded that one cancer death is prevented for every 1,904 women age 40 to 49 who are screened for 10 years, compared with one death for every 1,339 women age 50 to 74, and one death for every 377 women age 60 to 69.

    Many cancer groups opposed the decision, and it's easy to see why: their job is to ensure that no one, no matter how slim the odds, dies of cancer that could have been prevented. Proponents of evidence-based medicine say that mammograms lead to too many unnecessary tests and the detection of too many tumors that may not really need treatment. But as it turns out, mammograms themselves aren’t the problem.
    More
  • Brooke Magnanti's Surprisingly Logical Call Girl Confession: That's DR. Belle Du Jour To You

    Raina Kelley | Nov 17, 2009 01:25 PM

    Unless you’ve been in solitary confinement, you’re aware of the fact that Belle de Jour, blogger, former prostitute, and head of the Diary of a London Call Girl publishing empire has revealed herself to be Dr. Brooke Magnanti, research scientist at the Bristol Initiative for Research of Child Health.

    When she’s not blogging about her past sexploits, she using her Ph.D. in informatics, epidemiology, and forensic science to research the effects of pesticides on children.  How’s that for an unexpected spin on the whore-with-the-heart-of-gold theme?  I’m kinda jealous of her, I have to admit.  Magnanti is like a year of feminist studies rolled into one.  I would have loved to be the first credible candidate for one of feminism’s holy grails:  the empowered sex worker—able to expose herself to patriarchal fantasies of male domination without becoming damaged goods. 

    We may have to add her to our pantheon of saints right up there with Susan Faludi and Katha Pollitt. I don’t think I’ve ever heard a more level-headed and reasonable explanation for becoming a call-girl than this one by Magnanti:


    “I couldn’t find a professional job in my chosen field because I didn’t have my Ph.D. yet. I didn’t have a lot of spare time on my hands because I was still making corrections and preparing for the viva; and I got through my savings a lot faster than I thought I would. … What can I do that I can start doing straightaway, that doesn’t require a great deal of training or investment to get started, that’s cash in hand and that leaves me spare time to do my work in?”


    Is this woman a scientist or what?  Now before you go all ballistic and chastise either myself or Dr. Magnanti for our lack of moral fiber, let me add two things:  working as an escort is not illegal in the United Kingdom.  Yup, prostitution is above board in England—it’s the activities that make sex work a nasty dangerous enterprise that are illegal—no streetwalking, no pimps, no brothels.  Secondly, the idea that prostitution is the only commodified form of erotic activity is crazy.  Consider the Sports Illustrated swimsuit edition for a moment—$6.99 and all you get is the illusion of female sexuality.  Magnanti may well be the rare woman who can, as Gloria Steinem put it to Vermont Woman, “experience sexuality as power.…It’s not sexuality that’s the problem, it’s whose sexuality and why?”  That’s also why I can love Belle de Jour and still condemn human trafficking, the prostitution of children, and pimping without appearing hypocritical or naive.

    And lest you think I dodged the whole morality question, let me answer in more detail by punting to a smarter mind.  In Feminist Issues in Prostitution, Sarah Bromberg asserts that our stern disapproval of call girls stems “from an underlying assumption in conventional morality that involvement in prostitution will “necessarily” have degenerative effects on a person leading her to other criminal activities.…Prostitution is not a profound condition of degeneracy and in many instances it may be a self-regarding expression of a person surviving in the best way given their skills and opportunities.”  Take that, you Puritans!

    So, I’m a big fan of Dr. Magnanti now; I might even buy her new book, Belle de Jour’s Guide to Men. I have a feeling her point of view might be more interesting than the play-hard-to-get, treat-men-like-untrainable-dogs claptrap we women usually get. [As it turns out, the start of chapter one hits the "men are like untrainable dogs" metaphor pretty hard. I guess some stereotypes are hard to break, even if you're a pioneering scientist/call girl.]


  • New Report Claims That Many Probiotics Provide Fewer Live Cells Than Listed on Labels

    Johannah Cornblatt | Nov 16, 2009 03:27 PM

    Americans are spending more and more dollars each year on probiotic supplements, or so-called “friendly” bacteria. Studies have shown that probiotics—which you might purchase in the form of yogurt, capsules, miso, beverages, or powders—can treat a host of conditions, including irritable bowel syndrome, diarrhea caused by viral infection or antibiotics, vaginal yeast infections, hypertension, the common cold, and even acne. Over the past decade, consumer sales of probiotics in the U.S. have nearly quadrupled (growing from $115 million in 1998 to $425 million in 2008), according to Nutrition Business Journal.

    But, according to a report released today, many of the most popular probiotic supplements don’t contain the amount of live bacteria listed on their labels. ConsumerLab, a private company that tests health and nutritional products at independent labs across the country, found that at the time a consumer buys a probiotic, it may contain as little as 10 to 58 percent of the amount of viable organisms listed on the label. “It’s shocking how many products really don’t have what they claim on their labels,” says Tod Cooperman, the president of ConsumerLab. “The buyer has to be careful.”

    ConsumerLab purchased the probiotics as a consumer would, cultured the products to determine the number of viable cells in them, and compared the results to the amounts listed on the product labels. The company sent any product that did not contain the amount of live cells listed on the label to a second lab for additional testing. “We’re absolutely certain about what we found,” Cooperman says. Despite the misleading numbers, most products contained at least one billion organisms, which is probably enough to provide some—although not necessarily optimal—benefit, according to Cooperman. 

    Find out more about the findings after the jump. 

    More
  • Research Determines Exactly What All Women Want, All The Time, In Every Scenario...Except Not.

    Newsweek | Nov 16, 2009 01:07 PM

    by Leigh Bond

    Who says that women only like jerks? A new study published in the journal Science from Binghamton University and the University of Arizona adds yet another clue to the mystery that is female sexual selection.  "Mom was right," says the press release. "Nice guys don't always finish last."

    Of course, mom was probably not discussing the mating habits of bugs. Researchers in this study observed the effects of a controlled group of male water striders – both aggressive and low-key, and their sexual relations with the females in the group. According to the study led by Omar Tonsi Eldakar of the University of Arizona’s Arizona Research Laboratories, groups of “gentlemen” water striders mated with  more females than did groups of the “psychopath” suitors. The research contradicts previous laboratory studies finding sexually aggressive males more successful at reproducing, said Eldakar. In previous studies, the females were blocked from leaving the areas populated by the sexually aggressive males; this study showed that actually given a choice, the females would leave whenever the jerk bugs came around - the nice bugs got the girls.

    What does this have to do with you? Almost nothing. Find out why, after the jump. 

    More
  • The American Medical Association Reconsiders Marijuana. Will the Justice Department Follow?

    Jessica Bennett | Nov 13, 2009 02:44 PM
  • Charla Nash on Oprah: What Happened to Winfrey's "Chimp Lady" Gaffe?

    Jesse Ellison | Nov 13, 2009 12:41 PM
    ... I was among the 7.4 million Americans who tuned in on Wednesday to watch Oprah Winfrey interview Charla Nash, the woman tragically attacked by her friend’s pet chimpanzee back in February. If you were among us, you witnessed the deeply awkward moment... More
  • Helping a Fort Hood Victim: Friends Start Fund to Sponsor Wounded Soldier's Family Visit

    Newsweek | Nov 12, 2009 06:45 PM
    Alan Carrol at training in Fort Hood (courtesy of Alan Carrol). by Jeneen Interlandi In the wake of the Fort Hood shootings, many soldiers—including Alan Carrol, who I profiled earlier this week —are still struggling to reunite with loved ones. According... More
  • Emma Thompson's Polanski Reversal: Even Celebs Get Peer Pressured

    Raina Kelley | Nov 10, 2009 12:03 PM

    By now, news has reached the blogosphere that Emma Thompson has asked to remove her name from the online petition in support of Roman Polanski.  (Remember him?  He’s the famous director who was convicted of unlawful sexual contact with a minor.) 

    Turns out that one of her fans had the courage to ask her to reconsider her support of Polanski.  Well now, I feel stupid.  I too was heartbroken that Thompson had signed the petition. But I didn't do anything about it.  I just complained to my friends and sulked. Thompson, through the roles she has played, and her good works on an array of worthwhile causes she's devoted herself to, is a role model for us women who don't want to play cute to get ahead. But when she signed the petition, I just felt that she was another insular superstar whose strength and cool was just for show.  I am so glad I was wrong.

    But isn’t it amazing that one of the reasons Thompson says she signed in the first place was because she was getting tons and tons of calls from her film friends pressuring to sign?  You see, peer pressure doesn’t go away when you grow up and graduate from high school; it follows you wherever you go. (Sigh.) So, I’m hoping (without hope) that Thompson’s act becomes a cause célèbre and peer pressure will force all the other boldface names that I admire to also get their names removed (um, Wes Anderson, it’s your turn).  Should you be a celebrity who’s dying to take her name off and are too frightened—Emma just gave you cover.  Here, I’ll even spin it for you, free of charge.  Simply say something like this: “Emma’s courageous act has made me realize that I just didn’t know what I was signing.  A crime is a crime and nobody deserves special treatment.” 

    Oh and just so you don’t seem like a pushover you can also add something like: “But I also have serious concerns that Polanski didn’t get a fair trial last time around and we have to be careful that we’re punishing him for the right things.”  That way, you can get your famous friends off your back and do the right thing. 

    So far Thompson has denied our request for an interview but if we do get her on the line, we’ll thank her.


  • Making a Digital First Impression: Why You Can't Fake Your Facebook Profile

    Johannah Cornblatt | Nov 10, 2009 11:02 AM

    The photo showed a man in a T shirt and baseball cap standing on top of a mountain. Tien-Yi Lee, a Web-site designer who had joined Nerve.com’s online dating service, says she felt an instant connection. “I saw his picture, and he had a very kind of friendly, sparkly vibe,” she says. “He had a great smile.” A few days later, Lee met the man at a bar in Cambridge, Mass. Lee remembers thinking that the photo on Nerve provided a “very accurate” reflection of her date’s personality in real life. A year after marrying the man from the photo, Lee’s first impressions of her future husband still largely hold true. “The picture was in sync with who he is,” she says.

    Lee’s experience is common among those who meet on the Internet, according to a new study on the role of physical appearance in creating first impressions. The study, which will be published in next month’s issue of Personality and Social Psychology Bulletin, found that you can actually learn a great deal about a stranger’s personality from appearance alone.

    More than 700 million people worldwide are now using online social networking sites that showcase personal photographs, but few realize just how accurate first impressions online can be. The findings from this study and other research on personality suggest that the photos you post online provide a wealth of information about who you are—whether you like it or not.
    More
  • From Ft. Hood to Florida: Lots of Questions, Few Answers on the Psyche of Shooters

    Newsweek | Nov 6, 2009 05:35 PM
    by Rabeika Messina We don’t know much about suspected Ft. Hood killer Nidal Malik Hasan : there are reports he gave away his possessions. There are reports he was terrified of being deployed. And there’s the fact that prior to his killing spree, Hasan... More
  • "This Is a Betrayal": A Chaplain Discusses the Long Recovery From Fort Hood and the Lasting Legacy of PTSD

    Eve Conant | Nov 6, 2009 02:12 PM

    An ordained Baptist chaplain and army captain, Roger Benimoff spent two tours of duty in Iraq and months between deployments counseling soldiers in the U.S. During his career, he provided spiritual guidance to American soldiers through crises of faith, bereavement, and trauma until he himself broke down. While training and working as a chaplain at Walter Reed during the height of its crisis, Benimoff was diagnosed with chronic PTSD and spent months of treatment at some of the facilities where he trained as a caretaker. NEWSWEEK's Eve Conant has tracked Benimoff's experiences over the years, starting with his time at Walter Reed, and recently in a book about his experiences, Faith Under Fire. Benimoff retired from the army earlier this year. He spoke with Conant from Dallas, where he is a hospital chaplain, about what might have happened in Fort Hood, how the military families will cope with tragedy on the homefront, and why the army pushed him so far he had to leave.

    Is "contact" or "secondary" PTSD a genuine problem?

    Oh yes, definitely. I didn't have much time to counsel before I was deployed—I had only three weeks active duty before going over—but I would debrief my soldiers in Iraq all the time about events I was not present at. I remember when Eagle Troop had lost a soldier to a sniper and I did the CISD [Critical Incident Stress Debriefing]. I still have those images in my head. Or when one of Fox Troop's tanks went over a land mine. The soldiers told me about how the IED blew through their tank, how the driver's body was completely destroyed, how it was like spaghetti, and they were desperately trying to pull him out of the driver's seat while their command told them to leave the scene. They didn't leave him behind. But the tension of that, and their descriptions of that moment stay with me. When Eagle Troop lost a sergeant to an RPG, they told me about running into the hospital, seeing Iraq soldiers vomiting on the stairs after what they had just seen—walls covered in blood, brain matter on the floor. These images don't go away and I wasn't even there that day.

    More
  • Is Fort Hood a Harbinger? Nidal Malik Hasan May Be a Symptom of a Military on the Brink.

    Andrew Bast | Nov 6, 2009 08:30 AM

     

    What if Thursday's atrocious slaughter at Fort Hood only signals that the worst is yet to come? The murder scene Thursday afternoon at the Killeen, Texas, military base, the largest in the country, was heart-wrenching. Details remained murky, but at least 13 are dead and 30 wounded in a killing spree that may momentarily remind us of a reality that most Americans can readily forget: soldiers and their families are living, and bending, under a harrowing and unrelenting stress that will not let up any time soon. And the U.S. military could well be reaching a breaking point as the president decides to send more troops into Afghanistan.

    It's hard to draw too many conclusions right now, but we do know this: Thursday night, authorities shot and then apprehended the lone suspect, Maj. Nidal Malik Hasan. A psychiatrist who was set to deploy to Iraq at the end of the month, Hasan reportedly opened fire around the Fort Hood Readiness Center, where troops are prepared for deployments to Iraq and Afghanistan. And though this scene is a most extreme and tragic outlier, it comes at a time when the stress of combat has affected so many soldiers individually that it makes it increasingly difficult for the military as a whole to deploy for wars abroad. In an abrupt news conference, Lt. Gen. Robert Cone, the top commander at Fort Hood, said in response to the shooting that authorities would "increase the security presence" on the military base. On the surface, it seemed like a logical enough plan. But it makes one wonder how much any kind of lockdown will either get at the root causes of soldier stresses or better prepare them for more battle.

    More